Aspira Women’s Health Inc. (NASDAQ:AWH) Short Interest Update

Aspira Women’s Health Inc. (NASDAQ:AWH) was the recipient of a significant drop in short interest in January. As of January 15th, there was short interest totalling 356,900 shares, a drop of 18.6% from the December 31st total of 438,500 shares. Based on an average daily trading volume, of 100,900 shares, the short-interest ratio is presently 3.5 days. Currently, 2.9% of the company’s stock are sold short.

Aspira Women’s Health Trading Down 6.2 %

Aspira Women’s Health stock traded down $0.02 during trading on Friday, hitting $0.38. 166,625 shares of the company were exchanged, compared to its average volume of 70,015. The company has a market capitalization of $6.29 million, a P/E ratio of -0.31 and a beta of 1.42. The business’s 50 day moving average is $0.67 and its 200 day moving average is $0.88. Aspira Women’s Health has a 52 week low of $0.36 and a 52 week high of $5.62.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Aspira Women’s Health stock. Pine Valley Investments Ltd Liability Co bought a new stake in shares of Aspira Women’s Health Inc. (NASDAQ:AWH) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 31,200 shares of the company’s stock, valued at approximately $25,000. Pine Valley Investments Ltd Liability Co owned about 0.19% of Aspira Women’s Health at the end of the most recent reporting period. 12.19% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Separately, StockNews.com began coverage on shares of Aspira Women’s Health in a research report on Sunday, January 12th. They set a “hold” rating for the company.

Aspira Women’s Health Company Profile

Aspira Women’s Health, Inc engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.